PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31034197-0	2019	Pyrazine-Fused Triterpenoids Block the TRPA1 Ion Channel in Vitro and Inhibit TRPA1-Mediated Acute Inflammation in Vivo.	Pyrazines	0-8	transient receptor potential cation channel, subfamily A, member 1	Mus musculus	39-44	
31034197-0	2019	Pyrazine-Fused Triterpenoids Block the TRPA1 Ion Channel in Vitro and Inhibit TRPA1-Mediated Acute Inflammation in Vivo.	Pyrazines	0-8	transient receptor potential cation channel, subfamily A, member 1	Mus musculus	78-83	
31034197-6	2019	In subsequent whole-cell patch clamp recordings, the two most effective compounds (pyrazine-fused triterpenoids 8 and 9) displayed a reversible and dose- and voltage-dependent effect to block the TRPA1 ion channel at submicromolar concentrations.	Pyrazines	83-91	transient receptor potential cation channel, subfamily A, member 1	Mus musculus	196-201	
31034197-8	2019	The results introduce betulin-derived pyrazine-fused triterpenoids as promising novel antagonists of TRPA1 that are potentially useful in treating diseases with a TRPA1-mediated adverse component.	Pyrazines	38-46	transient receptor potential cation channel, subfamily A, member 1	Mus musculus	101-106	
31034197-8	2019	The results introduce betulin-derived pyrazine-fused triterpenoids as promising novel antagonists of TRPA1 that are potentially useful in treating diseases with a TRPA1-mediated adverse component.	Pyrazines	38-46	transient receptor potential cation channel, subfamily A, member 1	Mus musculus	163-168